Ibuprofen and Neural Mobilization Treatment in Carpal Tunnel Syndrome.
CompletedPhase 4NCT04328805
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In the present investigation, the pain reduction effect of median nerve neural mobilization and oral ibuprofen treatments will be compared to those produced by the absence of treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome.
Study details
- Official title
- Pain Reduction and Changes in Upper Limb Function Produced by Over the Counter Oral Ibuprofen and Median Nerve Neural Mobilization Versus the Lack of Treatment, in Carpal Tunnel Syndrome.
- Conditions
- Interventions
- Drug: ibuprofen tablets
- Other: Median nerve neural mobilization
- Sponsor
- Universidad Europea de Madrid
- Start date
- 2020-09-23
- Primary completion
- 2020-12-26
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Venezuela
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings). * Full understanding of written and spoken Spanish (language). * Participants must freely consent to participate. * The presence of positive Phalen and Tinel signs. * The presence of carpal tunnel syndrome signs and symptoms. Exclusion Criteria: * The lack to meet inclusion criterions. * The presence of cognitive impairment. * Tumors. * Cancer. * Upper limb surgery or trauma. * Pregnancy. * Deformities of the (affected) upper limb. * Recent skin injuries or infections (in the affected upper limb). * Autoimmune inflammatory conditions or flu type symptoms. * Allergy (or contraindication) to non steroidal anti inflammatory drugs (NSAID) * Participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive). * Metabolic neuropathy. * Obesity (body mass index over 30). * Participants who are not employed.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04328805